138 related articles for article (PubMed ID: 27691904)
1. Pharmacokinetics and estimated bioavailability of grapiprant, a novel selective prostaglandin E
Łebkowska-Wieruszewska B; Barsotti G; Lisowski A; Gazzano A; Owen H; Giorgi M
N Z Vet J; 2017 Jan; 65(1):19-23. PubMed ID: 27691904
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of grapiprant, a selective EP
Lebkowska-Wieruszewska B; De Vito V; Owen H; Poapholatep A; Giorgi M
J Vet Pharmacol Ther; 2017 Dec; 40(6):e11-e15. PubMed ID: 28459136
[TBL] [Abstract][Full Text] [Related]
3. Safety and toxicokinetic profiles associated with daily oral administration of grapiprant, a selective antagonist of the prostaglandin E2 EP4 receptor, to cats.
Rausch-Derra LC; Rhodes L
Am J Vet Res; 2016 Jul; 77(7):688-92. PubMed ID: 27347820
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic/pharmacodynamic evaluation of grapiprant in a carrageenan-induced inflammatory pain model in the rabbit.
De Vito V; Salvadori M; Poapolathep A; Owen H; Rychshanova R; Giorgi M
J Vet Pharmacol Ther; 2017 Oct; 40(5):468-475. PubMed ID: 27925221
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of grapiprant and effects on TNF-alpha concentrations following oral administration to horses.
Hoffmann SL; Seminoff K; McKemie DS; Kass PH; Knych HK
J Vet Pharmacol Ther; 2022 Sep; 45(5):467-472. PubMed ID: 35652132
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic comparison of oral tablet and suspension formulations of grapiprant, a novel therapeutic for the pain and inflammation of osteoarthritis in dogs.
Rausch-Derra LC; Rhodes L; Freshwater L; Hawks R
J Vet Pharmacol Ther; 2016 Dec; 39(6):566-571. PubMed ID: 27027634
[TBL] [Abstract][Full Text] [Related]
7. Determination of grapiprant plasma and urine concentrations in horses.
Cox S; Sommardahl C; Fortner C; Davis R; Bergman J; Doherty T
Vet Anaesth Analg; 2020 Sep; 47(5):705-709. PubMed ID: 32439238
[TBL] [Abstract][Full Text] [Related]
8. Absorption of grapiprant in red-tailed hawks (Buteo jamaicensis) is decreased when administered with food.
Rodriguez P; Paul-Murphy JR; Knych HK; Drazenovich TL; Hawkins MG
Am J Vet Res; 2022 May; 83(6):. PubMed ID: 35524955
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of a single oral dose of grapiprant in juvenile pigs (Sus scrofa domestica).
Kleine S; Hampton CE; Smith C; Bussieres G; Mulon PY; Seddighi R; Cox S; Smith J
J Vet Pharmacol Ther; 2023 Sep; 46(5):269-275. PubMed ID: 37493273
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of acetaminophen after intravenous and oral administration in fasted and fed Labrador Retriever dogs.
Sartini I; Łebkowska-Wieruszewska B; Lisowski A; Poapolathep A; Cuniberti B; Giorgi M
J Vet Pharmacol Ther; 2021 Jan; 44(1):28-35. PubMed ID: 32715494
[TBL] [Abstract][Full Text] [Related]
11. The intravenous and oral pharmacokinetics of lotilaner in dogs.
Toutain CE; Seewald W; Jung M
Parasit Vectors; 2017 Nov; 10(1):522. PubMed ID: 29089051
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of grapiprant administered to red-tailed hawks (
Rodriguez P; Paul-Murphy JR; Knych HK; Drazenovich TL; Hawkins MG
Am J Vet Res; 2021 Nov; 82(11):912-919. PubMed ID: 34669491
[TBL] [Abstract][Full Text] [Related]
13. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of thalidomide in dogs: can feeding affect it? A preliminary study.
Pierini A; Sartini I; Giorgi M; Łebkowska-Wieruszewska B; Lisowski A; Poapolathep A; Marchetti V
J Vet Sci; 2020 Sep; 21(5):e60. PubMed ID: 33016014
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the pharmacokinetics of oral amitriptyline and its active metabolite nortriptyline in fed and fasted Greyhound dogs.
Norkus C; Rankin D; KuKanich B
J Vet Pharmacol Ther; 2015 Dec; 38(6):619-22. PubMed ID: 25989225
[TBL] [Abstract][Full Text] [Related]
16. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two inhibitors of E-type prostanoid receptor four and carprofen in dogs with experimentally induced acute synovitis.
Budsberg SC; Kleine SA; Norton MM; Sandberg GS
Am J Vet Res; 2019 Nov; 80(11):1001-1006. PubMed ID: 31644340
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the safety of long-term, daily oral administration of grapiprant, a novel drug for treatment of osteoarthritic pain and inflammation, in healthy dogs.
Rausch-Derra LC; Huebner M; Rhodes L
Am J Vet Res; 2015 Oct; 76(10):853-9. PubMed ID: 26413822
[TBL] [Abstract][Full Text] [Related]
19. Detection and quantification of the selective EP4 receptor antagonist CJ-023423 (grapiprant) in canine plasma by HPLC with spectrofluorimetric detection.
Vito V; Saba A; Lee HK; Owen H; Poapolathep A; Giorgi M
J Pharm Biomed Anal; 2016 Jan; 118():251-258. PubMed ID: 26580822
[TBL] [Abstract][Full Text] [Related]
20. A Prospective, Randomized, Masked, Placebo-Controlled Multisite Clinical Study of Grapiprant, an EP4 Prostaglandin Receptor Antagonist (PRA), in Dogs with Osteoarthritis.
Rausch-Derra L; Huebner M; Wofford J; Rhodes L
J Vet Intern Med; 2016 May; 30(3):756-63. PubMed ID: 27075237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
